Literature DB >> 31933194

Exploration of T-Cell Diversity Using Mass Cytometry.

Kaitlin C O'Boyle1, Takuya Ohtani1, Sasikanth Manne1, Bertram Bengsch2, Sarah E Henrickson1,3, E John Wherry4,5, Cecile Alanio6,7.   

Abstract

T-cell diversity is multifactorial and includes variability in antigen specificity, differentiation, function, and cell-trafficking potential. Spectral overlap limits the ability of traditional flow cytometry to fully capture the diversity of T-cell subsets and function. The development of mass cytometry permits deep immunoprofiling of T-cell subsets, activation state, and function simultaneously from even small volumes of blood. This chapter describes our methods for mass cytometry and high-throughput data analysis of T cells in patient cohorts. We provide a pipeline that includes practical considerations when customizing a panel for mass cytometry. We also provide protocols for the conjugation and titration of metal-labeled antibodies (including two T-cell panels) and a staining procedure. Finally, with the aim to support translational science, we provide R scripts that contain a detailed workflow for initial evaluation of high-dimensional data generated from cohorts of patients.

Entities:  

Keywords:  Clustering; CyTOF; Data processing; High-throughput analysis; Mass cytometry; R; Systems biology; T cells

Mesh:

Substances:

Year:  2020        PMID: 31933194     DOI: 10.1007/978-1-0716-0266-9_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Pembrolizumab for B-cell lymphomas relapsing after or refractory to CD19-directed CAR T-cell therapy.

Authors:  Elise A Chong; Cécile Alanio; Jakub Svoboda; Sunita D Nasta; Daniel J Landsburg; Simon F Lacey; Marco Ruella; Siddharth Bhattacharyya; E John Wherry; Stephen J Schuster
Journal:  Blood       Date:  2022-02-17       Impact factor: 25.476

2.  Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival Outcomes.

Authors:  Cécile Alanio; Zev A Binder; Renee B Chang; MacLean P Nasrallah; E John Wherry; Donald M O'Rourke; Gregory L Beatty; Devora Delman; Joey H Li; Oliver Y Tang; Logan Y Zhang; Jiasi Vicky Zhang
Journal:  Cancer Immunol Res       Date:  2022-07-01       Impact factor: 12.020

3.  Immune Dysregulation in Human ITCH Deficiency Successfully Treated with Hematopoietic Cell Transplantation.

Authors:  Trusha Patel; Sarah E Henrickson; Emily K Moser; Natania S Field; Kelly Maurer; Noor Dawany; Maire Conrad; Nancy Bunin; Jason L Freedman; Jennifer Heimall; Danielle E Arnold; Jing Wang; Jonathan E Markowitz; Sarah Beth Payne-Poff; Kelli W Williams; Pierre A Russo; E John Wherry; Marcella Devoto; Paula Oliver; Kathleen E Sullivan; Judith R Kelsen
Journal:  J Allergy Clin Immunol Pract       Date:  2021-04-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.